Repeated course of rituximab for treatment of nephrotic syndrome in patients with chronic GVHD

• Published in: Bone marrow transplantation (Basingstoke) Vol. 45; no. 12; pp. 1758 - 1759
• Main Authors: Mellon-Reppen, S, Ratanatharathorn, V, Cronin, S, Uberti, J P
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01.12.2010; Nature Publishing Group
• Subjects: 692/699/1585; 692/699/249/1529; 692/700/565/1436; 692/700/565/545/576/1955; Adult; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy; Antibodies, Monoclonal, Murine-Derived - therapeutic use; Biological and medical sciences; Bone marrow, stem cells transplantation. Graft versus host reaction; Care and treatment; Cell Biology; Chronic Disease; Development and progression; Glomerulonephritis; Graft versus host reaction; Graft vs Host Disease - complications; Graft vs Host Disease - drug therapy; Hematology; Hematopoietic stem cells; Humans; Immunologic Factors - therapeutic use; Internal Medicine; letter-to-the-editor; Male; Medical sciences; Medicine; Medicine & Public Health; Middle Aged; Nephrology. Urinary tract diseases; Nephropathies. Renovascular diseases. Renal failure; Nephrotic syndrome; Nephrotic Syndrome - drug therapy; Nephrotic Syndrome - immunology; Public Health; Risk factors; Rituximab; Stem cell transplantation; Stem Cells; Transfusions. Complications. Transfusion reactions. Cell and gene therapy; Transplantation; Glomerulonephritis; Kidney disease; Antineoplastic agent; Human; Immunopathology; Graft versus host disease; Urinary system disease; Hematology; Stem cell; Hematopoietic cell; Rituximab; Nephrotic syndrome; Monoclonal antibody; Immunomodulator; Chronic; Treatment; Immunotherapy; Immunosuppressive agent
• ISSN: 0268-3369; 1476-5365
• DOI: 10.1038/bmt.2010.58